Submit your project to the ”la Caixa” Foundation Health Research Call from 20 October to 3 December.

29 de Setembro 2020

We are looking for the best projects to tackle the greatest challenges in health research covering 5 areas: Oncology, Neuroscience, Infectious Diseases, Cardiovascular and Metabolic Diseases and Enabling Technologies related to the previous four health areas.

The ”la Caixa” Foundation Health Research Call is now open for applications!

For the Call, project proposals, to be executed over up to 3 years, may be:

  • Individual projects: submitted by a single research organization (Host Organization, HO), requesting up to a maximum of €500,000.
  • Research consortium projects: submitted by at least two and no more than five research organizations and coordinated by the HO. Research consortium projects may request up to a maximum of €1,000,000.

Both individual and research consortium projects may also include non-profit civil society organizations (CSO), such as patients’ associations. Established companies may not form part of the cooperating organizations that carry out activities of the project.

The intention is to distribute this amount approximately equitably amongst the different thematic areas, but the final distribution will always depend on the quality and specific characteristics of the submitted proposals. The fact that the proposals are submitted as individual or as research consortium, or are basic, clinical or translational research projects will not in any case be a selection criterion during the evaluation process. The only selection criteria for assessing the proposals are those described in the Rules for participation.

The correct allocation of the budget, properly adjusted to the activities to be carried out, will be a strictly evaluated criterion during the selection process.

Host Organizations (HO). Projects submitted may be led by researchers from non-profit research organizations based in Spain or Portugal.

Project Leader (PL). The principal investigator at the host organization must also be the project leader who submits the proposal and coordinates overall execution of the project.

Research Performing Organizations(RPO). Any non-profit research organization localized in any country around world, which carries out activities of the project. In individual projects, the RPO is the host organization. In research consortia, there must be a minimum of two and a maximum of five RPOs (including the host organization). Research organizations with the same NIF or VAT number will be considered one sole organization.

Principal Investigators (PI). Each research performing organization must have a principal investigator responsible for performing the activities in the project carried out at their institution.

Civil Society Organizations (CSO). Both individual projects and research consortia may also include up to three non-profit civil society organizations that are not engaged in research as part of their usual activity (e.g. patients’ associations).

Companies. Established companies may not be members of the project team, but may receive funds as subcontracted.

Globally, the sum of the budget of all the organizations not located in Spain or Portugal may receive a maximum of 30% of the total project budget.

Team members. All team members should form part of the host organization (HO), the civil society organizations (CSO) or the research consortia.

Details of the eligibility criteria and required documentation to complete the application can be found in the Rules for participation.

Previous awardees. PLs of awarded projects in the three previous editions of the Health Research Call cannot apply as PLs for new proposals in this edition.

Threshold score in the previous Health Research call. In order to promote the quality of proposals, PLs of projects that scored less than 5.50 (from a maximum score of 8) in the peer reviewed assessment of the previous edition (HR20) will not be able to submit proposals to this edition (HR21).

Prospectively, the PL and PIs of projects that score less than 5.50 (from a maximum score of 8) in the peer review assessment of this edition (HR21), cannot be submit as PL in proposals of the next edition (HR22).

Are NOT eligible those projects developing studies whose results are subject to rights, of any nature, held by for-profit organizations before the submission of the proposal. In any case, “la Caixa Foundation reserves the right to reject proposals with a clear benefit to for-profit organizations.

Proposals are selected on the basis of a rigorous process that will be carried out by peer reviewers in accordance with the highest standards of quality, impartiality, objectivity and transparency.

The process consists of an initial pre-selection remote phase and a second selection phase of face-to-face interviews conducted by Selection Committees in each of the research areas.

 

More information HERE

0 Comments

Submit a Comment

O seu endereço de email não será publicado. Campos obrigatórios marcados com *

ÚLTIMAS

Cerca de 44 mil pessoas pessoas morreram em 2023 vítimas do VIH/sida em Moçambique

“Não queremos dizer que estamos satisfeitos com 44 mil mortes. Esses números preocupam-nos, principalmente os de pessoas que estão a morrer em resultado de não estarem a fazer tratamento e, se estão, não o fazem corretamente”, disse o secretário executivo do Conselho Nacional do Combate à Sida, Francisco Mbofana, em conferência de imprensa, antecipando o dia mundial da luta contra VIH/Sida, que se assinala anualmente em 01 de dezembro.

Ana Escoval: “Boas práticas e inovação lideram transformação do SNS”

Em entrevista exclusiva ao Healthnews, Ana Escoval, da Direção da Associação Portuguesa para o Desenvolvimento Hospitalar, destaca o papel do 10º Congresso Internacional dos Hospitais e do Prémio de Boas Práticas em Saúde na transformação do SNS. O evento promove a partilha de práticas inovadoras, abordando desafios como a gestão de talento, cooperação público-privada e sustentabilidade no setor da saúde.

Fundador da Joaquim Chaves Saúde morre aos 94 anos

O farmacêutico Joaquim Chaves, fundador da Joaquim Chaves Saúde, morreu hoje aos 94 anos, anunciou o grupo, afirmando que foi “referência incontornável na área da saúde” em Portugal.

MAIS LIDAS

Share This